These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8103818)

  • 61. A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.
    Sadowski M; Pankiewicz J; Scholtzova H; Ripellino JA; Li Y; Schmidt SD; Mathews PM; Fryer JD; Holtzman DM; Sigurdsson EM; Wisniewski T
    Am J Pathol; 2004 Sep; 165(3):937-48. PubMed ID: 15331417
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
    Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
    Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view.
    Bird TD
    Ann Neurol; 1995 Jul; 38(1):2-4. PubMed ID: 7611719
    [No Abstract]   [Full Text] [Related]  

  • 64. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
    Lucotte G; David F; Visvikis S; Leininger-Müller B; Siest G; Babron MC; Couderc R
    Lancet; 1993 Nov; 342(8882):1309. PubMed ID: 7901625
    [No Abstract]   [Full Text] [Related]  

  • 65. The involvement of lipids in Alzheimer's disease.
    Lim WL; Martins IJ; Martins RN
    J Genet Genomics; 2014 May; 41(5):261-74. PubMed ID: 24894353
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Genetic susceptibility to Alzheimer disease.
    Pericak-Vance MA; Haines JL
    Trends Genet; 1995 Dec; 11(12):504-8. PubMed ID: 8533168
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rare case offers clues to staving off Alzheimer's.
    Servick K
    Science; 2019 Nov; 366(6466):674. PubMed ID: 31699915
    [No Abstract]   [Full Text] [Related]  

  • 68. Neuronal death in Alzheimer's disease.
    Yanagisawa K
    Intern Med; 2000 Apr; 39(4):328-30. PubMed ID: 10801151
    [No Abstract]   [Full Text] [Related]  

  • 69. Apolipoprotein E genotype and Alzheimer's disease.
    Noguchi S; Murakami K; Yamada N
    Lancet; 1993 Sep; 342(8873):737. PubMed ID: 8103832
    [No Abstract]   [Full Text] [Related]  

  • 70. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
    Ben-Shlomo Y; Lewis G; McKeigue PM
    Lancet; 1993 Nov; 342(8882):1310. PubMed ID: 7901626
    [No Abstract]   [Full Text] [Related]  

  • 71. Apolipoprotein E genotype and Alzheimer's disease. Alzheimer's Disease Collaborative Group.
    Lancet; 1993 Sep; 342(8873):737-8. PubMed ID: 8103833
    [No Abstract]   [Full Text] [Related]  

  • 72. Apolipoprotein E is a relevant susceptibility gene that affects the rate of expression of Alzheimer's disease.
    Roses AD
    Neurobiol Aging; 1994; 15 Suppl 2():S165-7. PubMed ID: 7700444
    [No Abstract]   [Full Text] [Related]  

  • 73. Contemporary approaches to Alzheimer's disease and frontotemporal dementia.
    Roberson ED
    Methods Mol Biol; 2011; 670():1-9. PubMed ID: 20967579
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical application of apolipoprotein E genotyping to Alzheimer's disease.
    Roses AD; Strittmatter WJ; Pericak-Vance MA; Corder EH; Saunders AM; Schmechel DE
    Lancet; 1994 Jun; 343(8912):1564-5. PubMed ID: 7911881
    [No Abstract]   [Full Text] [Related]  

  • 75. Scopolamine-induced impairment as a potential predictor of Alzheimer's disease in individuals with Apolipoprotein E type 4 alleles.
    Pomara N; Nolan K; Halpern G
    Neurochem Res; 1995 Dec; 20(12):1519-20. PubMed ID: 8789616
    [No Abstract]   [Full Text] [Related]  

  • 76. The amplifying effect of beta-amyloid on cellular calcium signalling is reduced in Alzheimer's disease.
    Eckert A; Förstl H; Hartmann H; Czech C; Mönning U; Beyreuther K; Müller WE
    Neuroreport; 1995 May; 6(8):1199-202. PubMed ID: 7662907
    [TBL] [Abstract][Full Text] [Related]  

  • 77. How autism and Alzheimer's disease are TrAPPed.
    Lahiri DK; Maloney B; Wang R; Sokol DK; Rogers JT; Westmark CJ
    Mol Psychiatry; 2021 Jan; 26(1):26-29. PubMed ID: 33184495
    [No Abstract]   [Full Text] [Related]  

  • 78. Alzheimer's pathology begins to yield its secrets.
    Marx J
    Science; 1993 Jan; 259(5094):457-8. PubMed ID: 8424167
    [No Abstract]   [Full Text] [Related]  

  • 79. Future directions for research on Alzheimer's disease.
    Lieberburg I
    Neurobiol Aging; 1994; 15 Suppl 2():S117-9. PubMed ID: 7700434
    [No Abstract]   [Full Text] [Related]  

  • 80. Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.
    Nasica-Labouze J; Nguyen PH; Sterpone F; Berthoumieu O; Buchete NV; Coté S; De Simone A; Doig AJ; Faller P; Garcia A; Laio A; Li MS; Melchionna S; Mousseau N; Mu Y; Paravastu A; Pasquali S; Rosenman DJ; Strodel B; Tarus B; Viles JH; Zhang T; Wang C; Derreumaux P
    Chem Rev; 2015 May; 115(9):3518-63. PubMed ID: 25789869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.